GlassScriptPhysician profile
Alisa Alayan
NPI 1558745562
$4,586.28
in general payments reported to CMS, 2019-2025
14 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,488 · 2020: $48.42 · 2021: $1,146 · 2022: $40.83 · 2023: $106 · 2024: $393 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,363.15 | 2019 | |
| Alphatec Spine, INC | $547.03 | 2021-2022 | |
| Stryker Corporation | $297.97 | 2024 | Gamma |
| Medtronic, INC. | $266.33 | 2021-2025 | Intellis Adaptivestim |
| Kuros Biosciences USA, INC | $232.84 | 2021 | |
| Integrity Implants INC. | $171.61 | 2021 | |
| Spineology INC. | $147.49 | 2021 | |
| Glaxosmithkline, LLC. | $128.57 | 2022-2023 | Nucala |
| Depuy Synthes Sales INC. | $124.37 | 2019 | |
| Cardiva Medical, INC. | $102.67 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Globus Medical, INC. | $77.66 | 2021-2024 | Troch Nail |
| Augmedics INC. | $48.42 | 2020 | |
| Bioventus LLC | $39.99 | 2024 | Exogen Ultrasound Bone Healing System |
| Saxum Surgical, INC. | $38.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisa Alayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.